Lauren Dwyer MPH, MBA, RD
@Dwyer_Lauren_
Followers
33
Following
315
Statuses
136
rare disease patient advocate metabolic dietitian - nephrology medical science liaison - Travere
Chicago-ish
Joined May 2022
RT @jradnephro: THIS FRIDAY: Join us for Columbia's 14th Annual #Glomerular Disease program – a virtual conference on Friday, February 7, 2…
0
6
0
1
0
1
RT @goKDIGO: Join us on Tuesday, January 28, 2025, at 2:00 PM ET for "Understanding Genetic Testing Results: Case-Based Illustrations." R…
0
17
0
RT @AcidosisTubular: Not to be missed at #ISNWCN: Managing Rare Kidney Diseases Across the Lifespan: From Childhood to Adulthood. @IgAN_JB…
0
4
0
RT @LadanZand: Recurrent FSGS Post–Kidney Transplantations: Where Do We... : Transplantation In this editorial we discuss challenges of c…
0
19
0
RT @Brewers: We are heartbroken to announce that Brewers icon & Baseball Hall of Famer Bob Uecker passed away today at the age of 90 https:…
0
12K
0
RT @UDNconnect: 🔬 Congratulations to Dr. William Gahl and the entire UDP team for this feature in the Washingtonian magazine! Access the a…
0
2
0
RT @EricTopol: The gut microbiome signature from different diets in >20,000 individuals. Red meat intake correlated with reduced cardiometa…
0
374
0
RT @JIMD_Editors: I love a metabolic mystery and so I’m rather tickled by this new publication in Clinical Chemistry, detailing the: Diagno…
0
6
0
RT @hardik4u24: Managing glomerular disease recurrence post transplant? 🫘 Explore risk stratification & treatment pathways for FSGS, IgAN,…
0
47
0
RT @MayoClinicNeph: Enhancing Patient Comprehension of Glomerular Disease Treatments Using ChatGPT 📚 🤖 m @jingmiao2019 @wisit661 @Healthca…
0
15
0
RT @CKJsocial: First real-world evidence of sparsentan efficacy in patients with IgA nephropathy treated with SGLT2 inhibitors https://t.c…
0
39
0
RT @kidneyomicsamps: We are so grateful for the bipartisan support of Congressman @RepMoolenaar, Congresswoman @HaleyLive & @SenStabenow fo…
0
1
0
RT @OhioStateNeph: 🌟 Exciting News 🌟 Join Drs. @BradRovin & Jürgen Floege as they delve into the latest advancements in IgA Nephropathy man…
0
4
0
RT @ISGDtweets: Early career nephrologists, did you know @goKDIGO is starting a Guideline Methodology Fellowship program? Great opportunity…
0
5
0
RT @edgarvlermamd: Concomitant Sparsentan (SPAR) and SGLT2 Inhibitors (SGLT2i) in Adults with 🔬 IgA Nephropathy (IgAN) in the Ongoing Phas…
0
24
0
RT @TravereRare: We look forward to sharing our latest research in #RareKidneyDisease, including #IgAnephropathy and #FSGS at #KidneyWk 202…
0
2
0